Cas no 179625-38-8 (4-(3-Methoxy-3-oxopropyl)benzoic Acid)
4-(3-Methoxy-3-oxopropyl)benzoic Acid Chemical and Physical Properties
Names and Identifiers
-
- Benzenepropanoic acid, 4-carboxy-, -alpha--methyl ester (9CI)
- 4-[2-(METHOXYCARBONYL)ETHYL]BENZOIC ACID
- 4-(3-methoxy-3-oxopropyl)benzoic acid
- 4-(3-Methoxy-3-oxopropyl)benzoic Acid
-
- MDL: MFCD13659448
- Inchi: 1S/C11H12O4/c1-15-10(12)7-4-8-2-5-9(6-3-8)11(13)14/h2-3,5-6H,4,7H2,1H3,(H,13,14)
- InChI Key: WDYXTBQUPCLKQQ-UHFFFAOYSA-N
- SMILES: O(C)C(CCC1C=CC(C(=O)O)=CC=1)=O
4-(3-Methoxy-3-oxopropyl)benzoic Acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Matrix Scientific | 191838-1g |
4-(3-Methoxy-3-oxopropyl)benzoic acid, 95% |
179625-38-8 | 95% | 1g |
$578.00 | 2023-09-10 | |
| TRC | M575925-10mg |
4-(3-Methoxy-3-oxopropyl)benzoic Acid |
179625-38-8 | 10mg |
$ 50.00 | 2022-06-03 | ||
| TRC | M575925-50mg |
4-(3-Methoxy-3-oxopropyl)benzoic Acid |
179625-38-8 | 50mg |
$ 160.00 | 2022-06-03 | ||
| TRC | M575925-100mg |
4-(3-Methoxy-3-oxopropyl)benzoic Acid |
179625-38-8 | 100mg |
$ 250.00 | 2022-06-03 | ||
| Parkway Scientific | YB-260-1g |
4-(3-Methoxy-3-oxopropyl)benzoic acid |
179625-38-8 | > 95% | 1g |
$395 | 2024-05-21 | |
| Parkway Scientific | YB-260-3g |
4-(3-Methoxy-3-oxopropyl)benzoic acid |
179625-38-8 | > 95% | 3g |
$950 | 2024-05-21 | |
| Enamine | EN300-1700162-0.05g |
4-(3-methoxy-3-oxopropyl)benzoic acid |
179625-38-8 | 95.0% | 0.05g |
$82.0 | 2025-02-20 | |
| Enamine | EN300-1700162-0.1g |
4-(3-methoxy-3-oxopropyl)benzoic acid |
179625-38-8 | 95.0% | 0.1g |
$122.0 | 2025-02-20 | |
| Enamine | EN300-1700162-0.25g |
4-(3-methoxy-3-oxopropyl)benzoic acid |
179625-38-8 | 95.0% | 0.25g |
$173.0 | 2025-02-20 | |
| Enamine | EN300-1700162-0.5g |
4-(3-methoxy-3-oxopropyl)benzoic acid |
179625-38-8 | 95.0% | 0.5g |
$273.0 | 2025-02-20 |
4-(3-Methoxy-3-oxopropyl)benzoic Acid Related Literature
-
Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
-
Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
-
3. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imagingGhazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
-
Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
Additional information on 4-(3-Methoxy-3-oxopropyl)benzoic Acid
4-(3-Methoxy-3-oxopropyl)benzoic Acid (CAS No. 179625-38-8): An Overview of Its Properties, Applications, and Recent Research
4-(3-Methoxy-3-oxopropyl)benzoic Acid (CAS No. 179625-38-8) is a versatile organic compound that has garnered significant attention in the fields of chemistry, biochemistry, and pharmaceutical research. This compound, characterized by its unique structural features, has shown promise in various applications, including as an intermediate in the synthesis of pharmaceuticals and as a potential therapeutic agent. This article provides a comprehensive overview of the properties, applications, and recent research developments related to 4-(3-Methoxy-3-oxopropyl)benzoic Acid.
Chemical Structure and Properties
4-(3-Methoxy-3-oxopropyl)benzoic Acid is a carboxylic acid derivative with the molecular formula C11H12O4. The compound features a benzene ring substituted with a methoxyketone group at the para position. The presence of both the carboxylic acid and the methoxyketone functionalities imparts unique chemical and physical properties to this molecule. It is a white crystalline solid at room temperature and is soluble in common organic solvents such as ethanol, methanol, and dimethyl sulfoxide (DMSO).
The molecular weight of 4-(3-Methoxy-3-oxopropyl)benzoic Acid is 208.21 g/mol. Its melting point is approximately 150°C, and it has a pKa value of around 4.5, indicating that it can exist in both acidic and neutral forms depending on the pH of the solution. These properties make it suitable for various chemical reactions and biological assays.
Synthesis and Preparation
The synthesis of 4-(3-Methoxy-3-oxopropyl)benzoic Acid can be achieved through several methods. One common approach involves the reaction of 4-bromobenzoic acid with methyl acrylate in the presence of a palladium catalyst to form the intermediate ester, followed by hydrolysis to yield the final product. Another method involves the condensation of 4-formylbenzoic acid with dimethyl acetate, followed by oxidation to form the desired compound.
The choice of synthetic route depends on factors such as yield, purity, and cost-effectiveness. Recent advancements in green chemistry have led to the development of more environmentally friendly methods for synthesizing this compound, reducing waste and minimizing the use of hazardous reagents.
Applications in Pharmaceutical Research
4-(3-Methoxy-3-oxopropyl)benzoic Acid has shown potential as an intermediate in the synthesis of various pharmaceuticals. Its unique structure makes it a valuable building block for constructing more complex molecules with therapeutic properties. For instance, it has been used in the synthesis of anti-inflammatory agents, anticancer drugs, and antiviral compounds.
In recent studies, researchers have explored the use of 4-(3-Methoxy-3-oxopropyl)benzoic Acid as a lead compound for developing new drugs targeting specific biological pathways. One notable application is its use as a precursor for synthesizing inhibitors of protein kinases, which are key enzymes involved in cell signaling and proliferation. These inhibitors have shown promise in preclinical studies for treating various cancers.
Biochemical Properties and Mechanisms of Action
The biochemical properties of 4-(3-Methoxy-3-oxopropyl)benzoic Acid have been extensively studied to understand its potential therapeutic mechanisms. Research has shown that this compound can modulate various cellular processes by interacting with specific proteins or enzymes. For example, it has been found to inhibit certain enzymes involved in inflammation and oxidative stress, making it a potential candidate for treating inflammatory diseases.
In addition to its enzymatic inhibition properties, 4-(3-Methoxy-3-oxopropyl)benzoic Acid has also been investigated for its ability to modulate gene expression. Studies have demonstrated that it can affect the transcriptional activity of certain genes involved in cell survival and apoptosis. This property makes it an attractive candidate for developing drugs that target specific genetic pathways.
Clinical Trials and Future Prospects
The promising results from preclinical studies have led to increased interest in evaluating 4-(3-Methoxy-3-oxopropyl)benzoic Acid in clinical trials. Several Phase I and Phase II trials are currently underway to assess its safety and efficacy in treating various conditions. Preliminary data from these trials have shown encouraging results, with no major adverse effects reported.
The future prospects for this compound are promising. Ongoing research aims to optimize its pharmacological properties through structural modifications and formulation development. Additionally, efforts are being made to identify new targets and applications for this versatile molecule.
Conclusion
4-(3-Methoxy-3-oxopropyl)benzoic Acid (CAS No. 179625-38-8) is a multifaceted organic compound with significant potential in pharmaceutical research and development. Its unique chemical structure and biochemical properties make it a valuable tool for synthesizing new drugs and understanding biological processes. As research continues to advance, it is likely that this compound will play an increasingly important role in the discovery and development of novel therapeutics.
179625-38-8 (4-(3-Methoxy-3-oxopropyl)benzoic Acid) Related Products
- 22027-52-7(Methyl 4-methoxycarbonylbenzoylacetate)
- 125369-26-8(Methyl 4-(3-methoxy-3-oxopropanoyl)benzoate)
- 151937-09-6(4-(2-Carboxyethyl)benzoic Acid Methyl Ester)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)